Testing effectiveness (Phase 2)Study completedNCT02581657
What this trial is testing
Study to Assess the Safety, Tolerability, PK and PD Response of PE0139 Injection in Adult Subjects With T2DM
Who this might be right for
Type 2 Diabetes Mellitus
PhaseBio Pharmaceuticals Inc. 37